Clinical Trial Update: A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral etrasimod in adults with eosinophilic esophagitis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2023-10-26